Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD3 | Q15059 | 13/20 | 0.35 |
| ▸ | BRD4 | O60885 | 12/20 | 0.35 |
| ▸ | BRD2 | P25440 | 12/20 | 0.35 |
| ▸ | CREBBP | Q92793 | 12/20 | 0.35 |
| ▸ | MDM2 | Q00987 | 7/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | MDM4 | O15151 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22900325 | 0.81 | QPCT (0.40) | BRD3BRD4BRD2CREBBPMDM2 | |
| SCHEMBL22900327 | 0.80 | BRD4 (0.34) | BRD3BRD4BRD2CREBBPMDM2 | |
| SCHEMBL22900475 | 0.77 | BRD3 (0.37) | BRD3BRD4BRD2CREBBPMDM2 | |
| SCHEMBL22900661 | 0.77 | BRD3 (0.41) | BRD3BRD4BRD2CREBBPMDM2 | |
| SCHEMBL22900422 | 0.70 | QPCT (0.37) | — | |
| SCHEMBL22900326 | 0.65 | BRD2 (0.40) | BRD3BRD4BRD2CREBBPMDM2 | |
| SCHEMBL22900167 | 0.65 | QPCT (0.54) | — | |
| SCHEMBL22900328 | 0.64 | BRD2 (0.44) | BRD3BRD4BRD2CREBBP | |
| SCHEMBL22900459 | 0.63 | QPCT (0.40) | BRD3BRD4BRD2CREBBPMDM2 | |
| SCHEMBL22900466 | 0.60 | BRD3 (0.46) | BRD3BRD4BRD2CREBBPMDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021009068-A1 | N-SUBSTITUTED-3,4-(FUSED 5-RING)-5-PHENYL-PYRROLIDINE-2-ONE COMPOUNDS AS INHIBITORS OF ISOQC AND/OR QC ENZYME | SCENIC IMMUNOLOGY B.V. (NL) | 2021-01-21 | — | — | WO | disclosed |